Navigating the Landscape of Molecular Testing and Treatments With Targeted Therapies for Patients With Non-Small Cell Lung Cancer

November 7, 2015

Learning Objectives

  • Discuss evidence-based guidelines for the biopsy, histology, and molecular testing for diagnostic/prognostic markers
  • Describe scientific updates and key practice changes in the management of lung cancer, focusing on targeted including both new and investigational biologic therapies
  • Identify the common disease symptoms and/or side effects encountered in the management of non=small cell lung cancer and detail the best management strategies utilized by APs in oncology
  • Describe collaboration between various members of the healthcare team (including but not limited to physician, AP, and pharmacist) in the care of NSCLC
Course summary
Available credit: 
  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/07/2015
Course expires: 
02/29/2016
Event starts: 
11/07/2015 - 4:15pm
Event ends: 
11/07/2015 - 5:15pm
Cost:
$0.00
Rating: 
0
United States

Donald Harvey, PharmD, FCCP, BCOP
Sukhmani Padda, MD

Available Credit

  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.